NewCo Formation
Launch Your Assets Into New Markets
Partner with Vision Lifesciences to spin off your therapeutics and technologies into new independent entities, accessing global capital while retaining equity upside.
Global Capital Access
Secure substantial funding from international investors.
Equity Retention
Maintain ownership stake in the newly formed entity.
Risk Sharing
Share development risks with specialized partners.
Expert Network
Access global expertise and management talent.
Proven Track Record in NewCo Formation
We have helped clients across Asia and beyond launch successful NewCos that access global capital and accelerate asset development.
How Our NewCo Formation Process Works
From asset selection to NewCo launch, we guide you through every step of creating a successful new entity.
Asset Selection
We evaluate your portfolio to identify assets with high potential for spin-off and global development.
Structure Design
Design optimal corporate structure, governance, and deal terms including upfront payments, milestones, royalties, and equity retention.
Investor Sourcing
Connect with our network of specialized life sciences investors and strategic partners to secure funding.
NewCo Launch
Execute formation, establish management team, and support operational launch of the new entity.
Asset Selection
We evaluate your portfolio to identify assets with high potential for spin-off and global development.
Structure Design
Design optimal corporate structure, governance, and deal terms including upfront payments, milestones, royalties, and equity retention.
Investor Sourcing
Connect with our network of specialized life sciences investors and strategic partners to secure funding.
NewCo Launch
Execute formation, establish management team, and support operational launch of the new entity.
Who This Is For
Our NewCo formation services are designed for organizations looking to unlock asset value and access global markets through innovative corporate structures.
Biotech Companies
Early and mid-stage biotechs looking to spin off non-core assets or access global capital for pipeline advancement.
Pharmaceutical Companies
Established pharma seeking to monetize underutilized assets or accelerate global development through offshore structures.
Academic Spinouts
Universities and research institutions commercializing discoveries through newly formed corporate entities.
Why Choose Vision Lifesciences for NewCo Formation
Our unique combination of cross-border expertise, investor network, and hands-on approach makes us the ideal partner for NewCo formation.
Navigate complex cross-border structures with confidence.
The NewCo model requires navigating different regulatory environments, corporate structures, and investor expectations across jurisdictions. Our team has facilitated numerous cross-border NewCo formations, helping clients structure deals that work in both Eastern and Western markets.